The Ministry of Health (MoH) alerted the public to two cosmetic products found to be adulterated with undeclared, potent Western medicine after testing by the Laboratory of Pharmacy Section, Department of Scientific Services, MoH.
The cosmetic products are Dollys Pinky Night Advanced Cream whose manufacturer is unknown and Wardah Lightening Night Cream manufactured in Indonesia. Both products were found to be adulterated with mercury.
The adulterant found in this product can cause adverse effects that are potentially hazardous to the people using them. Mercury is a potent ingredient that is prohibited in cosmetic products as stipulated in the Medicines (Cosmetic Products) Regulations 2007.
It is prohibited due to its hazardous effects on human health. It is readily absorbed through the skin on topical application and tends to accumulate in the body. Exposure to mercury can cause skin rashes, memory loss and muscle weakness while high exposures may result in damage to the brain and kidneys. It is also extremely toxic to unborn children.
The MoH has not issued any approval for importation for the sale of these products and/or Cosmetic Notification Acknowledgement Letter for the sale of the rest of affected products. Following these findings, the products are not allowed to be imported and sold in Brunei Darussalam.
Members of the public who have purchased or used these products are advised to stop using them immediately. They should also consult a medical practitioner should they feel unwell or experience undesirable reactions as a result of using the products.
Members of the public involved in the retail of these products (including online retail such as through Facebook) are reminded that it is an offence under the Medicines (Cosmetic Products) Regulations, 2007, to import and market cosmetic products in the local market without a Cosmetic Product Notification Acknowledgement Letter issued by the authority. The penalty for contravening these regulations upon conviction is a fine not exceeding BND5,000, imprisonment for a term not exceeding two years or both.
The MoH called upon the public for their cooperation to report to the Compliance and Licensing Section if any of these products are still found on the market. For information, contact the Compliance and Licensing Section at 2393298 extension 208; send an e-mail to [email protected]; visit the 1st Floor, Compliance and Licensing Section, Department of Pharmaceutical Services Building, Kampong Madaras, Mukim Gadong ‘A’; or call the Darussalam hotline 123.